Institutional shares held 109 Million
8K calls
15.9K puts
Total value of holdings $1.14B
$83K calls
$165K puts
Market Cap $1.65B
159,899,008 Shares Out.
Institutional ownership 68.22%
# of Institutions 222


Latest Institutional Activity in CERT

Top Purchases

Q3 2024
Kopion Asset Management, LLC Shares Held: 381K ($3.94M)
Q3 2024
Baldwin Brothers LLC Shares Held: 14.6K ($152K)
Q3 2024
Handelsbanken Fonder Ab Shares Held: 22.3K ($231K)
Q3 2024
Sg Americas Securities, LLC Shares Held: 20.3K ($210K)
Q3 2024
Harbor Capital Advisors, Inc. Shares Held: 20.1K ($208K)

Top Sells

Q3 2024
Riverbridge Partners LLC Shares Held: 2.4M ($24.8M)
Q3 2024
New York State Common Retirement Fund Shares Held: 61.3K ($634K)
Q3 2024
Raymond James & Associates Shares Held: 71.3K ($738K)
Q3 2024
New York State Teachers Retirement System Shares Held: 63.8K ($660K)
Q3 2024
Trust Point Inc. Shares Held: 20.7K ($215K)

About CERT

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.


Insider Transactions at CERT

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
335K Shares
From 18 Insiders
Grant, award, or other acquisition 108K shares
Exercise of conversion of derivative security 227K shares
Sell / Disposition
216K Shares
From 10 Insiders
Payment of exercise price or tax liability 122K shares
Open market or private sale 94.1K shares

Track Institutional and Insider Activities on CERT

Follow Certara, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CERT shares.

Notify only if

Insider Trading

Get notified when an Certara, Inc. insider buys or sells CERT shares.

Notify only if

News

Receive news related to Certara, Inc.

Track Activities on CERT